13 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
24524217	65	Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronates.	Hokkaido University
27563406	128	Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors.	Roche Pharma Research and Early Development
30639896	42	Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles.	Hangzhou Institute of Innovative Medicine
30587447	3	Analysis of chain length, substitution patterns, and unsaturation of AM-404 derivatives as 20S proteasome stimulators.	Purdue University
31801019	5	Novel Cell-Penetrating Peptide Conjugated Proteasome Inhibitors: Anticancer and Antifungal Investigations.	University of Auckland
17249727	8	Cinnabaramides A-G: analogues of lactacystin and salinosporamide from a terrestrial streptomycete.	Intermed Discovery Gmbh (Imd)
15780623	39	Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.	Numazu Bio-Medical Research Institute
7608891	7	Potent inhibitors of proteasome.	Cephalon
11992770	19	Structure-based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.	Novartis Pharma
29652143	22	Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example.	Monash University